Itron (NASDAQ:ITRI) Rating Lowered to Hold at Wall Street Zen

Itron (NASDAQ:ITRI) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday.

A number of other research firms also recently weighed in on ITRI. Weiss Ratings reissued a “buy (b)” rating on shares of Itron in a research report on Wednesday, October 8th. Roth Capital upped their price objective on Itron from $130.00 to $150.00 and gave the company a “buy” rating in a research note on Tuesday, July 22nd. JPMorgan Chase & Co. increased their price objective on Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Thursday. Guggenheim reissued a “buy” rating and issued a $155.00 target price (up from $133.00) on shares of Itron in a research report on Monday, July 14th. Finally, Johnson Rice lowered Itron from a “buy” rating to an “accumulate” rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $138.10.

Itron Trading Down 2.2%

Shares of Itron stock opened at $131.33 on Friday. Itron has a 1 year low of $90.11 and a 1 year high of $140.04. The firm has a market cap of $6.00 billion, a PE ratio of 22.45, a P/E/G ratio of 0.72 and a beta of 1.48. The stock has a fifty day moving average price of $124.08 and a 200-day moving average price of $120.90. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.29. The company had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Equities research analysts anticipate that Itron will post 5.33 EPS for the current year.

Insider Buying and Selling at Itron

In related news, SVP Justin K. Patrick sold 388 shares of the business’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $48,620.28. Following the sale, the senior vice president directly owned 20,761 shares in the company, valued at approximately $2,601,560.91. The trade was a 1.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Joan S. Hooper sold 970 shares of the firm’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares of the company’s stock, valued at approximately $11,076,652.14. This represents a 1.09% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,037 shares of company stock worth $380,566. Company insiders own 1.51% of the company’s stock.

Institutional Investors Weigh In On Itron

A number of institutional investors and hedge funds have recently modified their holdings of the company. Impax Asset Management Group plc bought a new stake in Itron during the second quarter valued at $91,998,000. Norges Bank purchased a new stake in shares of Itron in the 2nd quarter valued at about $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Itron by 129.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock valued at $76,713,000 after acquiring an additional 413,487 shares during the last quarter. Merewether Investment Management LP grew its holdings in shares of Itron by 1,552.7% during the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after purchasing an additional 282,587 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its holdings in shares of Itron by 21.2% during the second quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company’s stock worth $124,201,000 after purchasing an additional 165,300 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.